Pear Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:PEAR   4:00:00 PM EDT
1.85
+0.08 (+4.52%)
4:09:44 PM EDT: $1.81 -0.04 (-2.16%)
Earnings Announcements

Pear Therapeutics Inc Sees FY 2022 Net Revenue $14-16 Million

Published: 11/14/2022 23:23 GMT
Pear Therapeutics Inc - Ordinary Shares - Class A (PEAR) - Sees FY 2022 Net Revenue $14-16 Million.
Q3 Revenue $4.1 Million.
Pear Therapeutics Reports Third Quarter 2022 Results.
Qtrly Loss per Share $0.22.
Sees FY 2022 Net Revenue $14 Million -16 Million.
Q3 Earnings per Share View $-0.21, Revenue View $4.0 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $4.81 Million
Adjusted EPS is expected to be -$0.22

Next Quarter Revenue Guidance is expected to be $5.75 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.